| CASE SERIES |
|
| Year : 2017 | Volume
: 8
| Issue : 4 | Page : 177-181 |
|
|
Levosulpiride-induced movement disorders
Supriyo Choudhury1, Koustav Chatterjee1, Ravi Singh1, Shantanu Shubham1, Santosh Trivedi1, Suparna Chatterjee2, Hrishikesh Kumar1
1 Department of Neurology, RGC Research Centre, Institute of Neurosciences, Kolkata, West Bengal, India
2 Department of Pharmacology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India
Correspondence Address:
Hrishikesh Kumar
Department of Neurology and RGC Research Centre, Institute of Neurosciences, 185/1 AJC Bose Road, Kolkata - 700 017, West Bengal
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jpp.JPP_32_17
|
|
|
We reported a series of patients who presented with LSP.induced movement disorders specifically, dyskinetic movements. We have presented one case of LSP-induced parkinsonism and summarized ten cases of LSP-induced dyskinesia. The causality of the adverse drug reaction was assessed systematically using a validated rating system, and we extensively qualified the clinical presentation of each case of dyskinesia using a clinical rating scale. We described an unusual case of acute onset LSP-induced parkinsonism in a 56-year-aged female. The mean age of ten patients of LSP-induced dyskinesia was 65.3 years (standard deviation 10.4), and 25% of patients were female. They were consuming suspected medication for a median duration of 13 months (range 1–60 months). We noted LSP-induced dyskinesia was challenging to treat as its resolution is often incomplete even with adequate treatment.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
